Healthy subjects, gastric and duodenal ulcers, gastric MALT lymphoma, gastric cancer, gastritis
Conditions
Interventions
None listed
Sponsors
Kyorin University School of Medicine
Tokai University School of Medicine, Tokyo Medical University Hospital, Oita University School of Medicine, Hirosaki University Hospital, Kenwakai Hospital, Hakodate Medical Center, Aichi Medical University Hospital, Takeda Clinic, Kitasato University Hospital, Kayaba-cho Clinic, Public Interest Foundation Hokkaido Cancer Society, Kawasaki Medical School Hospital, Juntendo University Hospital, Keio University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those who visit Kyorin University Hospital and facilities participating in this research and undergo an upper gastrointestinal endoscopy as an insurance treatment or medical examination. (2) The criteria for participation are (1) if the subject of the clinical trial "Fact-finding of Helicobacter spp. other than Helicobacter pylori that infects the human stomach" continues to participate, that is, if the subject suffers from gastroduodenal disease and tests positive for NHPH. Or 2) Those who are strongly suspected of having NHPH infection clinically and histologically and require detailed examination. (3) Those who have given verbal and written consent to participate in this study.
Exclusion criteria
Exclusion criteria: (1) Persons who are unable to consent to participate in this study. (2) Persons who lack the capacity to consent to this study. (3) In the case of endoscopic biopsy, those who the attending physician judges to be prone to bleeding. (4) Pregnant women and women who may be pregnant. (5) Persons whose survival rate at the time of examination is less than 5 years. (6) Persons with definite proof of Helicobacter pylori infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Evaluation of drug susceptibility of NHPH 2. Identification of the infection route by genomic analysis of NHPH | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Clarification of the bacterial species that infect the human stomach in NHPH infection 2. Evaluation of patient background (age, illness, history of keeping pets, etc.) of NHPH infection 3. Evaluation of endoscopic findings of NHPH infection 4. Evaluation of gastric bacterial flora in NHPH-infected patients 5. Evaluation of diagnostic methods for NHPH infection using blood, stool, gastric juice, culture, and tissue 6. Evaluation of gastritis in NHPH infection 7. Changes in the above tests after NHPH eradication | — |
Countries
Japan
Contacts
Public ContactKENGO TOKUNAGA
Kyorin University School of Medicine Department of Preventive Medicine
Outcome results
None listed